These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7659888)

  • 1. [Lipoprotein (a), atherosclerosis, and diabetes mellitus].
    Martínez MT; Pérez F; Calvillán M; Gutiérrez-López MD; Serrano-Ríos M
    Rev Med Chil; 1994 Oct; 122(10):1189-95. PubMed ID: 7659888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
    Koschinsky ML; Marcovina SM
    Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lp(a) serum concentrations in diabetes mellitus].
    Murakami J; Kumasaka K; Kawano K; Murakami T; Hayashi Y; Arakawa Y
    Rinsho Byori; 1994 Dec; 42(12):1273-8. PubMed ID: 7869592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I; Cetinarslan B; Cantürk Z
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics].
    Mudríková T; Tkác I; Takác M
    Vnitr Lek; 1994 Apr; 40(4):250-4. PubMed ID: 8184588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
    Muchacka-Bianga M; Deja G; Jarosz-Chobot P; Małecka-Tendera E; Kalina M; Grychtoł M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):25-30. PubMed ID: 16704858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein(a) phenotypes and lipoprotein(a) in type 1 diabetes mellitus patients and their first-degree relatives.
    Cardoso-Saldaña G; Bravo-Rios LE; Torres-Tamayo M; Zamora-González J; Posadas-Romero C
    Rev Invest Clin; 2003; 55(6):662-9. PubMed ID: 15011736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease.
    Maca T; Mlekusch W; Doweik L; Budinsky AC; Bischof M; Minar E; Schillinger M
    Eur J Clin Invest; 2007 Mar; 37(3):180-6. PubMed ID: 17359485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    Clin Chim Acta; 2006 Nov; 373(1-2):127-31. PubMed ID: 16820145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein (a) in coronary artery disease in Indian population.
    Govindaraju V; Neelam ; Manjunath CN; Sundar KK
    J Indian Med Assoc; 2003 Aug; 101(8):458-60, 462. PubMed ID: 15071797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) and its role in occlusive vascular disease.
    Tennant M; McGeachie JK
    Ann R Coll Surg Engl; 1993 Jan; 75(1):3-7. PubMed ID: 8422141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes].
    Głowińska B; Urban M; Koput A
    Pol Merkur Lekarski; 2002 Feb; 12(68):108-14. PubMed ID: 11995245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein(a). Its relationship with atherosclerosis and diabetes].
    Martínez MT; Pérez F; Calvillán M; Gutiérrez-López MD; Serrano Ríos M
    Rev Clin Esp; 1994 May; 194(5):361-7. PubMed ID: 8059034
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
    Couderc R; Maachi M
    J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.